Zenas BioPharma, Inc.(ZBIO) - 2024 Q4 - Annual Results

Exhibit 99.1 Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases WALTHAM, Mass, February 5, 2025 (GLOBE NEWSWIRE) – Zenas BioPharma, Inc. ("Zenas" or the "Company") (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced its 2024 accomplishments, outlined it ...